Thursday, December 8, 2011

Gilead donates $8M of 'black sickness' drug to WHO

Gilead Sciences Inc. will donate 445,000 vials of AmBisome over five years to help the World Health Organization treat more than 50,000 patients with “black fever,” or visceral leishmaniasis.
Based on Gilead's no-profit price through its access program for developing countries, the donation is valued at more than $8 million.

No comments:

Post a Comment